Phytochemistry 2013-04-01

Seasonal accumulation of major alkaloids in organs of pharmaceutical crop Narcissus Carlton.

Andrea Lubbe, Henk Gude, Robert Verpoorte, Young Hae Choi

Index: Phytochemistry 88 , 43-53, (2013)

Full Text: HTML

Abstract

Narcissus pseudonarcissus (L.) cv. Carlton is being cultivated as a main source of galanthamine from the bulbs. After galanthamine, haemanthamine and narciclasine are the next most abundant alkaloids in this cultivar. Both these compounds are promising chemical scaffolds for potential anticancer drugs. For further research and drug development, a reliable supply of these compounds will be needed. In this study a field experiment was conducted to investigate the levels of galanthamine, haemanthamine and narciclasine in plants of N. pseudonarcissus cv. Carlton. In a field experiment alkaloids in the bulbs, leaves and roots were analyzed by quantitative (1)H NMR to monitor the variations during the growing season. Major primary and secondary metabolites were identified in the various plant parts. Multivariate data analysis was performed on the (1)H NMR spectra to investigate how metabolites changed in the plant organs over time. The results show that the leaves have relatively high concentrations of the alkaloids before flowering. The bulbs had lower concentrations of the compounds of interest but would have a higher total yield of alkaloids due to bigger biomass. Narcissus pseudonarcissus cv. Carlton represents a good source of galanthamine, and can potentially be a source of the other major alkaloids depending on choice of organ and harvest time.Copyright © 2012 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity.

2014-12-29

[J. Chromatogr. A. 1374 , 122-33, (2014)]

Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases.

2015-07-28

[Nanoscale 7 , 12076-84, (2015)]

Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors.

2015-04-01

[J. Neurophysiol. 113 , 2195-209, (2015)]

Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells.

2015-11-01

[Int. Immunopharmacol. 29 , 31-5, (2015)]

Free energy, precision and learning: the role of cholinergic neuromodulation.

2013-05-08

[J. Neurosci. 33(19) , 8227-36, (2013)]

More Articles...